Scott Edwin Lewis

Title: Scott Edwin Lewis: Innovator in Heat Shock Protein Research

Introduction

Scott Edwin Lewis is a notable inventor based in Westminster, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides that interact with heat shock proteins. His innovative work has implications for both diagnosis and therapy in medical science.

Latest Patents

Scott Edwin Lewis holds a patent for "Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy." This patent describes peptides that comprise an α-helix forming-amino acid sequence that binds to heat shock proteins. The invention includes a polypeptide that consists of a first peptide portion with an α-helix-forming amino acid sequence and at least one second peptide portion that enhances the interaction with the heat shock protein. The applications of these peptides and polypeptides extend to fractionating substances relevant for discovery, research, or clinical analysis from biological samples, as well as their use as therapeutics.

Career Highlights

Throughout his career, Scott has worked with various organizations that focus on cancer research and peptide synthesis. Notably, he has been associated with the Atlantic Cancer Research Institute and New England Peptide, Inc. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Scott Edwin Lewis has collaborated with Steven Gareth Griffiths, enhancing the scope and impact of his research endeavors. Their partnership has likely fostered innovative approaches to the challenges in their field.

Conclusion

Scott Edwin Lewis is a distinguished inventor whose work on heat shock proteins has the potential to revolutionize therapeutic approaches in medicine. His contributions to the field are marked by his innovative patent and collaborations with other professionals.